ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      17,168.35
      0.63%
      Dow Jones
      38,085.80
      -0.98%
      Brent Oil
      88.185
      0.04%
      Bitcoin
      64,119.45
      -0.57%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Entrada Therapeutics Inc (TRDA)

      7. Entrada Therapeutics Inc (TRDA) News

      TRDA Entrada Therapeutics Inc

      12.36
      -0.07 (-0.56%)
      Apr 25 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Entrada Therapeutics Inc TRDA NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.07 -0.56% 12.36 16:00:10
      Open Price Low Price High Price Close Price Prev Close
      12.23 11.91 12.58 12.36 12.43
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      3/13/202407:00GLOBEEntrada Therapeutics Reports Fourth Quarter and Full Year..
      3/08/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:22EDGAR2Form 144 - Report of proposed sale of securities
      3/06/202416:22EDGAR2Form 144 - Report of proposed sale of securities
      3/05/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202407:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
      1/03/202407:16EDGAR2Form 8-K - Current report
      1/03/202407:00GLOBEEntrada Therapeutics Promotes Nathan J. Dowden to President
      12/26/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/21/202316:26EDGAR2Form 144 - Report of proposed sale of securities
      12/06/202307:00EDGAR2Form 8-K - Current report
      11/22/202311:56DJNEntrada Therapeutics Shares Tumble 27% After FDA Keeps..
      11/22/202307:54DJNEntrada: FDA Declines to Lift Hold on Duchenne Study
      11/22/202307:35EDGAR2Form 8-K - Current report
      11/22/202307:00GLOBEEntrada Therapeutics Announces Updates on ENTR-601-44 in..
      11/07/202307:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/07/202307:08EDGAR2Form 8-K - Current report
      11/07/202307:00GLOBEEntrada Therapeutics Reports Third Quarter 2023 Financial..
      11/01/202307:01EDGAR2Form 8-K - Current report
      10/12/202307:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
      9/29/202316:39EDGAR2Form 8-K - Current report
      9/29/202316:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      9/21/202307:09EDGAR2Form 8-K - Current report
      9/21/202307:00GLOBEEntrada Therapeutics Announces First Participant Dosed in..
      9/07/202307:00GLOBEEntrada Therapeutics Awards Funding to Non-Profit..
      9/06/202317:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/06/202317:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/06/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/06/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/06/202316:09EDGAR2Form 144 - Report of proposed sale of securities
      9/06/202316:09EDGAR2Form 144 - Report of proposed sale of securities
      9/06/202316:08EDGAR2Form 144 - Report of proposed sale of securities
      9/05/202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/05/202316:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
      8/29/202307:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
      8/10/202307:09EDGAR2Form 8-K - Current report
      8/10/202307:00GLOBEEntrada Therapeutics Appoints Gina Chapman to its Board of..
      8/08/202307:25EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
      8/08/202307:23EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
      8/08/202307:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/08/202307:07EDGAR2Form 8-K - Current report
      8/08/202307:00GLOBEEntrada Therapeutics Reports Second Quarter 2023 Financial..
      8/04/202316:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/02/202316:10EDGAR2Form 144 - Report of proposed sale of securities
      8/01/202307:08EDGAR2Form 8-K - Current report
      8/01/202307:00GLOBEEntrada Therapeutics Receives Authorization in the United..
      7/12/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      TRDA
      Entrada Therapeutics
      Delayed Upgrade Clock